Mucuna pruriens (L.) DC (Leguminosae)

ANUSHA, B.; VIDHYA, V.G.; RAMYA, M. Hypoglycemic effect of Mucuna pruriens seed extract on normal and streptozotocin-diabetic rats. Fitoterapia, v.79, p.539-543, 2008. BRAVO, P.A.F.; NASSIF, M.C. Doença de Parkinson: Terapêutica atual e avançada. Pharmacia Brasileira, v.55, p.25-29, 2006. BUCKLES, D. Velvet bean (Mucuna pruriens): A “new” plant with a history. Economic Botany, v.49, p.13-25, 1995. CAIUS, J.F. The medicinal and poisonous legumes of India. Scientific Publichers, p. 70-71, 1989. CHANÁ, P. Advances in the medical treatment of Parkinson’s disease. Parkinsonism Related Disorders, v. 15, p. S22-S25, 2009. EKANEM, A.P.; OBIEKEZIE, A.; KLOAS, W.; KNOPF, K. Effects of crude extracts of Mucuna pruriens (Fabaceae) and Carica papaya (Caricaceae) against the protozoan fish parasite Ichthyophthirius multifiliis. Parasitology Research, v. 5, p. 361-366, 2004. FERRAZ, H.B. Agonistas Dopaminérgicos no tratamento da Doença de Parkinson. Revista Neurociência, v.12, n.4, p. 192-197, 2004. GIROLAMI, U.D.O. Sistema nervoso central. In: Patologia Estrutural e Funcional. Rio de Janeiro: Guanabara Koogan, p.1171-1224, 1996. GUERRANTI, R.; AGUIYI, J.C.; ERRICO, E.; PAGANI,R.; MARINELLO, E. Effects of Mucuna pruriens extract on activation of prothrombin by Echis carinatus venom. Journal of Ethnopharmacology, v.75, p.175-180, 2001. GUPTA, M.; MAZUMDER, U.K.; CHAKRABORTI, S.; BHATTACHARYA, S.; RATH, N.; BHOWAL, S.R. Anti-epieptic and anticancer activity of some indigenous plants. Indian Journal Physiology and Allied Sciences, v.51, n.2, p.53-56, 1997. HAUSER, R.A. Early pharmacologic treatment in Parkinson’s disease. American Journal Managed Care, v.16, p.S100-S107, 2010. HUISDEN, C.M.; ADESOGAN, A.T.; GASKIN, J.M.; COURTNEY, C.H.; RAJI, A.M.; KANG, T. Effect of feeding Mucuna pruriens on helminth parasite infestation in lambs. Journal of Ethnopharmacology, v.127, n.3, p.669-673, 2010. HUSSAIN, G.; MANYAM, B.V. Mucuna pruriens proves more effective than L-Dopa in Parkinson’s disease animal model. Phytotherapy, v.6, p.419-23, 1997. JENNER P. Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson’s disease. Current Opinion Neurology, v.16, p.S3-S7, 2003. KAAKOLA, S.; GORDIN, A.; MANNISTO, P.T. General properties and clinical possibilities of new selesctive inhibitors of cathecol-O-methyltransferase. General Pharmacology, v.25, p.813-824, 1994. KASSUBEK, J.; BUTTNER, T.; REICHMANN, H.; RIEDERER, P.; SCHULZ, J.B.; WULLNER, U.; CSOTI, I. On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson’s disease. Fortschritte der Neurologie Psychiatrie, v.78, p.S34-S36, 2010. KASTURE, S; PONTIS, S.; PINNA, A.; SCHINTU, N.; SPINA, L.; LONGONI, R.; SIMOLA, N.; BALLERO, M.; MORELLI, M. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson’s disease. Neurotoxicity Research, v.15, n.2, p.111-122, 2009. KATZENSCHLAGER, R.; EVANS, A.; MANSON, A.; PATSALOS, P. N.; RATNARAJ N.; WATT H.; TIMMERMANN, L.; VAN DER GIESSEN R.; LEES A. J. Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study. Journal of Neurology Neurosurgery Psychiatry, v.75, p.1672-1677, 2004. KOROLKOVAS, A.; FRANÇA, F.F.A.C. Depressores do sistema nervoso central. In: Dicionário Terapêutico Guanabara. 9ª Ed. (2002/2003). Rio de Janeiro: Guanabara Koogan. p. 1.20-1.25, 2004. MANYAM, B.V.; DHANASEKARAN, M.; HARE T.A. Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytotherapy Research, v.18, n.9, p.706-712, 2004. MANYAM, B. V.; SÁNCHEZ-RAMOS, J. R. Traditional and complementary therapies in Parkinson’s disease. Advanced Neurology, v.80, p.565-574, 1999. MANYAM, B.V. Paralysis agitans and levodopa in “Ayurveda”: ancient Indian medical treatise. Movement Disorders, v.5, p.47-48, 1990. MEINCKE, U.; KOSINSKI, C.M. Treatment of mental disorders in patients with Parkinson’s disease. Journal of Neurology Neurosurgery Psychiatry, v.5, p.279-287, 2010. MISRA, L.; WAGNER, H. Extraction of bioactive principles from Mucuna pruriens seeds. Indian Journal of Biochemistry Biophysics, v.44, p.56-60, 2007. NAGASHAYANA, N.; SANKARANKUTTY, P.; NAMPOOTHIRI, M.R.; MOHAN, P.K.; MOHANAKUMAR, K.P. Association of L-DOPA with recovery following Ayurveda medication in Parkinson’s disease. Journal of the Neurological Sciences, v.176, n.2, p.124-147, 2000. OBESO J.A.; RODRIGUEZ-OROZ, M.C.; RODRIGUEZ, M.; MACIAS, R.; ALVAREZ L.; GURIDI, J.; VITEK, J.; DELONG, M.R. Pathophysiologic basis of surgery for Parkinson’s disease. Neurology, v.55, p.S7-S12, 2000. PANT, M.C.; UDDIN, I.; BHARDWAJ, U.R.; TEWARI, R.D. Blood sugar and total cholesterol lowering effect of Glicine Soja, Mucuna pruriens (D.C.) and Dolichos Diflorus (Linn.) seed diets in normal fasting albino rats. Indian Journal of Medical Research, v.12, p.1808-1811, 1968. RAJESHWAR, Y.; GUPTA, M.; MAZUMDER, U.K. Antitumour acticity and in vitro antioxidant status of Mucuna pruriens (Fabaceae) against Ehrlich Ascites Carcinoma in Swiss Albino Mice. Iranian Journal of Pharmacology e Therapeutics, v.1, p.46-53, 2005a. RAJESHWAR, Y.; GUPTA, M.; MAZUMDER, U.K. In vitro lipid peroxidation and antimicrobial activity of M. pruriens seeds. Iranian Journal of Pharmacology and Therapeutics, v.1, p.32-35, 2005b. RATHI, S.S.; GROVER, J.K.; VATS, V. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytotherapy. Research, v. 3, p. 236-243, 2002a. RATHI, S.S.; GROVER, J.K.; VIKRANT, V.; BISWAS, N.R. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytotherapy. Research, v.8, p.774-747, 2002b. SATHIYANARAYANAN, L.; ARULMOZHI, S. Mucuna pruriens Linn. - A comprehensive review. Pharmacognosy Review, v.1, n.1, p.157-162, 2007. SHUKLA, K.K.; MAHDI, A.A.; AHMAD M.K.; SHANKHWAR, S.N.; RAJENDER, S.; JAISWAR, S.P. Mucuna pruriens improves male fertility by its action on the hypothalamuspituitary-gonadal axis. Fertility and Sterility, v.92, n.6, p.1934-1940, 2009. SINGHAL, B.; LALKAKA, J.; SANKHLA C. Epidemiology and treatment of Parkinson’s disease in India. Parkinsonism Related Disorders, v.9, n.2, p.S105-S109, 2003. SPENCER, J.P, WHITEMAN, M., JENNER, P., HALLIWELL, B. 5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. Journal of Neurochemistry, v.81, p.122-129, 2002. STANDAERT, D.G.; YOUNG, A.B. Tratamentos dos distúrbios degenerativos do sistema nervoso central. In: As bases farmacológicas da terapêutica. Goodman & Gilman. Ed. Mc Graw Hill, Santiago, 1996. p.367-378. STOWE, R.; IVES, N.; CLARKE, C.E.; DEANE, K.; HILTEN, V.; WHEATLEY, K.; GRAY, R.; HANDLEY, K.; FURMSTON, A. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson’s disease patients with motor complications. Cochrane Database Systematic. Reviews, v.7, p.7-16, 2010. SURESH, S.; PRITHIVIRAJ, E.; PRAKASH, S. Dose- and time-dependent effects of ethanolic extract of Mucuna pruriens Linn. seed on sexual behaviour of normal male rats. Journal of Ethnopharmacology, v.122, n.3, p.497-501, 2009. TAN, N.H.; FUNG, S.Y.; SIM, S.M.; MARINELLO, E.; GUERRANTI, R.; AGUIYI,J.C. The protective effect of Mucuna pruriens seeds against snake venom poisoning. Journal of Ethnopharmacology, v.123, p.356-358, 2009. THARAKAN, B.; DHANASEKARAN, M.; MIZE-BERGE, J.; MANYAM, B. V. Anti-Parkinson botanical Mucuna pruriens prevents levodopa induced plasmid and genomic DNA damage. Phytotherapy Research, v.21, n.12, p.1124-1126, 2007. VAIDYA, A.B.; RAJAGOPALAN, T.G.; MANKODI, N.A.; ANTARKAR, D.S.; TATHED, P.S.; PUROHIT, A.V.; WADIA N.H.Treatment of Parkinson’s disease with the cowhage plant - Mucuna pruriens. Neurology India, v.26, p.171-176, 1978.